VOYA Investment Management
ABMD

VOYA Investment Management’s Abiomed Inc ABMD Stock Holding History

VOYA Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-28,326
Closed -$6.96M – 2962
2022
Q3 		$6.96M Sell
28,326
-461
-2% -$124K 0.01% 833
2022
Q2 		$7.13M Sell
28,787
-2,981
-9% -$804K 0.02% 596
2022
Q1 		$10.5M Sell
31,768
-694
-2% -$214K 0.02% 605
2021
Q4 		$11.7M Buy
32,462
+7,900
+32% +$2.67M 0.02% 544
2021
Q3 		$8M Sell
24,562
-535
-2% -$181K 0.02% 658
2021
Q2 		$7.83M Sell
25,097
-1,635
-6% -$502K 0.02% 703
2021
Q1 		$8.52M Sell
26,732
-1,131
-4% -$362K 0.02% 635
2020
Q4 		$9.03M Sell
27,863
-162,533
-85% -$45M 0.02% 613
2020
Q3 		$52.8M Buy
190,396
+59,858
+46% +$17.2M 0.12% 171
2020
Q2 		$31.5M Buy
130,538
+102,071
+359% +$20.5M 0.07% 229
2020
Q1 		$4.13M Sell
28,467
-434
-2% -$72K 0.01% 746
2019
Q4 		$4.93M Buy
28,901
+4,023
+16% +$746K 0.01% 801
2019
Q3 		$4.43M Sell
24,878
-198
-0.8% -$42.8K 0.01% 831
2019
Q2 		$6.53M Buy
25,076
+1,295
+5% +$344K 0.01% 726
2019
Q1 		$6.79M Sell
23,781
-2,050
-8% -$681K 0.02% 684
2018
Q4 		$8.4M Sell
25,831
-50,222
-66% -$17.4M 0.02% 590
2018
Q3 		$34.2M Sell
76,053
-23,811
-24% -$9.39M 0.07% 284
2018
Q2 		$40.8M Buy
99,864
+13,298
+15% +$4.82M 0.09% 247
2018
Q1 		$25.2M Buy
86,566
+67,261
+348% +$17M 0.05% 356
2017
Q4 		$3.62M Sell
19,305
-34,094
-64% -$6.37M 0.01% 895
2017
Q3 		$9M Sell
53,399
-8,082
-13% -$1.22M 0.02% 627
2017
Q2 		$8.81M Sell
61,481
-350,155
-85% -$47.1M 0.02% 644
2017
Q1 		$51.5M Buy
411,636
+189,415
+85% +$22M 0.12% 172
2016
Q4 		$25M Sell
222,221
-74,430
-25% -$8.62M 0.06% 308
2016
Q3 		$38.1K Buy
296,651
+52,880
+22% +$6.33M 0.07% 221
2016
Q2 		$26.6M Sell
243,771
-78,655
-24% -$7.83M 0.07% 280
2016
Q1 		$30.6M Sell
322,426
-78,112
-20% -$6.59M 0.08% 245
2015
Q4 		$36.2M Buy
400,538
+60,035
+18% +$5.09M 0.09% 220
2015
Q3 		$31.6M Buy
340,503
+318,813
+1,470% +$28.1M 0.08% 245
2015
Q2 		$1.43M Sell
21,690
-1,176
-5% -$78.1K ﹤0.01% 1230
2015
Q1 		$1.64M Hold
22,866
– – ﹤0.01% 1184
2014
Q4 		$870K Sell
22,866
-1,801
-7% -$56.8K ﹤0.01% 1531
2014
Q3 		$612K Sell
24,667
-2,140
-8% -$54.2K ﹤0.01% 1762
2014
Q2 		$674K Hold
26,807
– – ﹤0.01% 1768
2014
Q1 		$698K Hold
26,807
– – ﹤0.01% 1722
2013
Q4 		$717K Buy
26,807
+4,219
+19% +$104K ﹤0.01% 1693
2013
Q3 		$431K Hold
22,588
– – ﹤0.01% 2018
2013
Q2 		$487K Buy
+22,588
New +$454K ﹤0.01% 1850

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

VOYA Investment Management's ABMD Position: Q4 2022 in Review

VOYA Investment Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 28,326 shares — an estimated $6.96M sold.

VOYA Investment Management first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $52.8M in Q3 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • VOYA Investment Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • VOYA Investment Management sold 28,326 Abiomed Inc shares in Q4 2022, an estimated $6.96M.
  • VOYA Investment Management first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
  • VOYA Investment Management's Abiomed Inc position peaked at $52.8M in Q3 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on VOYA Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.